BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6486243)

  • 1. Quantitative indexes of aminonucleoside-induced nephrotic syndrome.
    Nevins TE; Gaston T; Basgen JM
    Am J Pathol; 1984 Oct; 117(1):30-6. PubMed ID: 6486243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminonucleoside nephrosis in rats. Ultrastructural findings in the glomerulus by concomitant influence of indomethacin and aminonucleoside.
    Sessa A; Conte F; Cioffi A; D'Amico GD
    Nephron; 1975; 14(3-4):299-308. PubMed ID: 1128753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.
    Abe H; Shibuya T; Odashima S; Arichi S; Nagase S
    Nephron; 1988; 50(4):351-5. PubMed ID: 3237275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular basement membrane anionic charge site changes early in aminonucleoside nephrosis.
    Mahan JD; Sisson-Ross S; Vernier RL
    Am J Pathol; 1986 Nov; 125(2):393-401. PubMed ID: 3789094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined light and electron-microscope morphometric studies of acute puromycin aminonucleoside nephropathy in rats.
    Pinto JA; Brewer DB
    J Pathol; 1975 Jul; 116(3):149-64. PubMed ID: 1104792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A morphometric, biochemical and histochemical comparison of puromycin aminonucleoside and hyperalbuminaemic induced proteinurias in the female Wistar rat.
    Lawrence GM; Brewer DB
    J Pathol; 1983 Feb; 139(2):115-40. PubMed ID: 6827398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of protamine on proteinuria and glomerular sclerosis in aminonucleoside nephropathy.
    Saito T; Yamakage K; Kurosawa K; Kyogoku Y; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1982 Apr; 136(4):461-2. PubMed ID: 7101279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Podocyte Vesicle Transcytosis and Albuminuria in
    Hatakeyama S; Tojo A; Satonaka H; Yamada NO; Senda T; Ishimitsu T
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats.
    Löwenborg EK; Jaremko G; Berg UB
    Nephrol Dial Transplant; 2000 Oct; 15(10):1547-55. PubMed ID: 11007821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro.
    Fishman JA; Karnovsky MJ
    Am J Pathol; 1985 Mar; 118(3):398-407. PubMed ID: 3976843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
    Hoyer JR; Mauer SM; Michael AF
    J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporine on puromycin aminonucleoside-induced nephrotic rats.
    Shibasaki T; Matsuda H; Nakano H; Matsumoto H; Miyahara T
    J Chemother; 1989 Jun; 1(3):211-5. PubMed ID: 2795127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
    Higuchi A
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome.
    Smoyer WE; Mundel P; Gupta A; Welsh MJ
    Am J Physiol; 1997 Jul; 273(1 Pt 2):F150-7. PubMed ID: 9249603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
    Klein DJ; Dehnel PJ; Oegema TR; Brown DM
    Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do large pores in the glomerular capillary wall account for albuminuria in nephrotic states?
    Vuchkova J; Koltun M; Greive K; Comper WD
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F525-32. PubMed ID: 24990894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase.
    Kinugasa S; Tojo A; Sakai T; Tsumura H; Takahashi M; Hirata Y; Fujita T
    Kidney Int; 2011 Dec; 80(12):1328-38. PubMed ID: 21849973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
    Garin EH; Shirey AJ
    Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD; Bertram JF; Ryan GB
    J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.